Cargando…

ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-β copathology

INTRODUCTION: Apolipoprotein E (ApoE) is the most important genetic risk factor for Alzheimer's disease (AD), with ApoE4 thought to enhance and accelerate amyloid-β (Aβ) pathology. ApoE4 has recently been described to increase neurodegeneration in a mouse model of frontotemporal dementia (FTD),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koriath, Carolin, Lashley, Tammaryn, Taylor, William, Druyeh, Ronald, Dimitriadis, Athanasios, Denning, Nicola, Williams, Julie, Warren, Jason D., Fox, Nick C., Schott, Jonathan M., Rowe, James B., Collinge, John, Rohrer, Jonathan D., Mead, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430720/ https://www.ncbi.nlm.nih.gov/pubmed/30949567 http://dx.doi.org/10.1016/j.dadm.2019.01.010

Ejemplares similares

Temporal Variant Frontotemporal Dementia Is Associated with Globular Glial Tauopathy
por: Clark, Camilla N., et al.
Publicado: (2015)

Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features
por: Mahoney, Colin J., et al.
Publicado: (2012)

The clinical, neuroanatomical, and neuropathologic phenotype of TBK1-associated frontotemporal dementia: A longitudinal case report
por: Koriath, Carolin A.M., et al.
Publicado: (2016)

Clinical considerations in early-onset cerebral amyloid angiopathy
por: Banerjee, Gargi, et al.
Publicado: (2023)

A pathogenic progranulin mutation and C9orf72 repeat expansion in a family with frontotemporal dementia
por: Lashley, Tammaryn, et al.
Publicado: (2014)

In vivo staging of frontotemporal lobar degeneration TDP-43 type C pathology
por: Bocchetta, Martina, et al.
Publicado: (2020)

Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration
por: Woollacott, Ione O. C., et al.
Publicado: (2020)

Advances in the Understanding of Frontotemporal Dementia
por: Bandopadhyay, Rina, et al.
Publicado: (2023)

Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration
por: Rohrer, Jonathan D., et al.
Publicado: (2011)

Heritability in frontotemporal tauopathies
por: Forrest, Shelley L., et al.
Publicado: (2019)

HnRNP Pathologies in Frontotemporal Lobar Degeneration
por: Jiang, Xinwa, et al.
Publicado: (2023)

Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia
por: Fratta, Pietro, et al.
Publicado: (2013)

Plasma tau is increased in frontotemporal dementia
por: Foiani, Martha S, et al.
Publicado: (2018)

Two pathologically confirmed cases of novel mutations in the MAPT gene causing frontotemporal dementia
por: Shafei, Rachelle, et al.
Publicado: (2020)

A novel prion protein variant in a patient with semantic dementia
por: Kenny, Joanna, et al.
Publicado: (2017)

Epigenetic Age Acceleration in Frontotemporal Lobar Degeneration: A Comprehensive Analysis in the Blood and Brain
por: Murthy, Megha, et al.
Publicado: (2023)

Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
por: Rohrer, Jonathan D., et al.
Publicado: (2016)

The TMEM106B risk allele is associated with lower cortical volumes in a clinically diagnosed frontotemporal dementia cohort
por: Harding, Sophie R, et al.
Publicado: (2017)

Exome sequencing reveals a novel partial deletion in the progranulin gene causing primary progressive aphasia
por: Rohrer, Jonathan D, et al.
Publicado: (2013)

A novel TBK1 mutation in a family with diverse frontotemporal dementia spectrum disorders
por: Lamb, Ruth, et al.
Publicado: (2019)

The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis
por: Bampton, Alexander, et al.
Publicado: (2020)

Pathological correlates of white matter hyperintensities in a case of progranulin mutation associated frontotemporal dementia
por: Woollacott, Ione O.C., et al.
Publicado: (2018)

Frontotemporal dementia
por: Warren, Jason D, et al.
Publicado: (2013)

Profiles of white matter tract pathology in frontotemporal dementia
por: Mahoney, Colin J., et al.
Publicado: (2014)

An update on genetic frontotemporal dementia
por: Greaves, Caroline V., et al.
Publicado: (2019)

In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome
por: Giannini, Giulia, et al.
Publicado: (2022)

Looking beneath the surface: the importance of subcortical structures in frontotemporal dementia
por: Bocchetta, Martina, et al.
Publicado: (2021)

Defining the presymptomatic phase of frontotemporal dementia
por: Russell, Lucy L., et al.
Publicado: (2023)

Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations()
por: Rohrer, Jonathan D., et al.
Publicado: (2010)

CSF synaptic protein concentrations are raised in those with atypical Alzheimer’s disease but not frontotemporal dementia
por: Clarke, Mica T. M., et al.
Publicado: (2019)

Altered body schema processing in frontotemporal dementia with C9ORF72 mutations
por: Downey, Laura E, et al.
Publicado: (2014)

Soluble and insoluble dipeptide repeat protein measurements in C9orf72-frontotemporal dementia brains show regional differential solubility and correlation of poly-GR with clinical severity
por: Quaegebeur, Annelies, et al.
Publicado: (2020)

Influence of APOE genotype in primary age-related tauopathy
por: Robinson, Andrew C., et al.
Publicado: (2020)

Impact of APOE genotype on prion-type propagation of tauopathy
por: Williams, Tristan, et al.
Publicado: (2022)

Predictors for a dementia gene mutation based on gene-panel next-generation sequencing of a large dementia referral series
por: Koriath, C., et al.
Publicado: (2018)

Longitudinal Diffusion Tensor Imaging in Frontotemporal Dementia
por: Mahoney, Colin J, et al.
Publicado: (2015)

Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases
por: Thompson, Andrew G. B., et al.
Publicado: (2021)

Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup
por: Woollacott, Ione O. C., et al.
Publicado: (2018)

Presymptomatic studies in genetic frontotemporal dementia
por: Rohrer, J.D., et al.
Publicado: (2013)

Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest
por: Foiani, Martha S, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_poma421l97m58nkgjd1vr2o3h7